Decrease risk. Lower failure rate. Increase speed to market.
Our unique technology enables us to print large amounts of DNA with game-changing throughput and quality. With that as our foundation, Twist Biopharma is able to create unprecedented synthetic antibody libraries, accelerating the way you discover, optimize, and develop lead antibody candidates. Twist Biopharma offers tailored services and workflows to your individual needs such as:
Here's what our customers are saying
Twist is the only synthetic DNA provider who can deliver the quantity and quality of DNA we need for our projects rapidly. We are working with them not only as a vendor for synthetic genes and antibodies, but have expanded our relationship to leverage the Biopharma capabilities, which we believe complement our antibody discovery efforts.
Robert Carnahan, Ph.D.
Associate Director of the Vanderbilt Vaccine Center
Twist Biopharma Brochure
Twist Biopharma is committed to helping you realize the potential of your biggest biologic development programs. Wherever you are in the development pipeline, we have a solution that will elevate you to the next level of discovery.
Twist Antibody Optimization Platform: Creating higher affinity antibody variants
Dr. Tom Yuan presents a poster discussing the TAO Platform used to optimize a low-affinity antibody through its custom algorithm
Webinar: Writing the Future of Biologics
Certain products are subject to use restrictions as set forth in Twist's Supply Terms and Conditions